Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial

Por Arrieta, Alejandro, Hong, Jonathan C., Khera, Rohan, Virani, Salim S., Krumholz, Harlan M., Nasir, Khurram
Publicado no JAMA Cardiol (2017)

Burden of Catastrophic Health Expenditures for Acute Myocardial Infarction and Stroke among Uninsured in the United States

Por Khera, Rohan, Hong, Jonathan C, Saxena, Anshul, Arrieta, Alejandro, Virani, Salim S, Blankstein, Ron, de Lemos, James A, Krumholz, Harlan M, Nasir, Khurram
Publicado no Circulation (2017)